San Antonio Breast Cancer Symposium 2025
The 2025 San Antonio Breast Cancer Symposium, hosted by UT Health San Antonio and the American Association for Cancer Research, took place from December 9-12, 2025. The symposium featured the latest research in the prevention, diagnosis, and treatment of premalignant breast disease and breast cancer, including data from late-breaking clinical trials. Each year, the symposium attracts thousands of basic scientists, physician-scientists, clinical investigators, breast care providers, and advocates from around the world.
Made with Visme Presentation Maker
mEDIA cOVERAGE
See highlights of media coverage featuring research presented at the San Antonio Breast Cancer Symposium 2025 below.
NBC News Triple-negative breast cancer vaccine shows promise in early clinical trial
Learn More
TIME A New Study Challenges the Way We Screen for Breast Cancer
Learn More
The New York Times Risk-Based Screening Works as Well as Yearly Checks After 40 in Finding Breast Cancers
Learn More
Reuters Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial
Learn More
Fierce Biotech Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial
Learn More
MedPage Today More Support for Omitting Lymph Node Biopsy in Low-Risk Early Breast Cancer
Learn More
HealthDay A Conversation with SABCS Co-Director Dr. Virginia Kaklamani and Presenter Dr. Isabelle Bedrosian
Learn More
Medscape Acupuncture May Aid Cognition in Breast Cancer Survivors
Learn More
The Cancer Letter Ben Ho Park, Sara Tolaney to receive awards at 2025 San Antonio Breast Cancer Symposium
Learn More
Read the press releases and watch the press conferences from the meeting’s official press program.